Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics

Pei-Ling Hsieh; Cheng-Chia Yu

doi:10.3390/ijms23116110

Oral Fibrosis and Oral Cancer: From Molecular Targets to Therapeutics

Int J Mol Sci. 2022 May 30;23(11):6110. doi: 10.3390/ijms23116110.

Authors

Pei-Ling Hsieh¹, Cheng-Chia Yu^{2

3

4}

Affiliations

¹ Department of Anatomy, School of Medicine, China Medical University, Taichung 404333, Taiwan.
² School of Dentistry, Chung Shan Medical University, Taichung 40201, Taiwan.
³ Department of Dentistry, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
⁴ Institute of Oral Sciences, Chung Shan Medical University, Taichung 40201, Taiwan.

Abstract

Oral submucous fibrosis (OSF) belongs to a group of potentially malignant disorders that are characterized by the progressive fibrosis of the lining mucosa as well as an increasing loss of tissue mobility [...].

Publication types

Editorial

MeSH terms

Fibrosis
Humans
Mouth Mucosa / pathology
Mouth Neoplasms* / drug therapy
Mouth Neoplasms* / etiology
Mouth Neoplasms* / pathology
Oral Submucous Fibrosis* / drug therapy
Oral Submucous Fibrosis* / etiology
Oral Submucous Fibrosis* / pathology

Grants and funding

This work was supported by grants from the Ministry of Science and Technology (grant number: MOST 110-2628-B-040-001) in Taiwan.